GUTS — FRACTYL HEALTH, INC. COMMON STOCK (Healthcare >> Biotechnology)
GUTS FAQ
What is GUTS's P/E ratio?
FRACTYL HEALTH, INC. COMMON STOCK (GUTS) currently trades at a P/E ratio of 13.59.
What is GUTS's ROE?
FRACTYL HEALTH, INC. COMMON STOCK reports a Return on Equity (ROE) of -505.22%.
What is GUTS's dividend yield?
FRACTYL HEALTH, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is GUTS's Deepscope Quality Score?
Deepscope rates GUTS's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GUTS?
Deepscope's AI Timing Score for GUTS is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GUTS belong to?
FRACTYL HEALTH, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.76
Price
-0.03
(-3.76%)
Day Change
|
|
|---|
GUTS Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 90 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.76 |
| PBV / Sector |
5.86 / 4.48
|
| Earning Per Share | -0.66 |
| PE / Sector |
13.59 / 16.68
|
| PEG or PE/Growth / Sector |
0.50 / 0.53
GOOD
|
| Average 1M Daily Value |
1.93 M
GREAT
|
| Average 1W Daily Value |
1.16 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
39% |
| Khả năng kiếm lợi nhuận |
|
47% |
| Lợi tức cho nhà đầu tư |
|
8% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-04 09:24:12 |
| Symbol | GUTS |
| Name | FRACTYL HEALTH, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 158.65 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 125.29 / 8,483.11 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3 Van de Graaff Drive, Burlington, MA, United States, 01803
Phone: 781 902 8800
Website: https://fractyl.com
Employees: 100
Sector: Healthcare >> Biotechnology
Description: Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google